Study Evaluating the Safety Feasibility and Efficacy of ODI-2001 Vaccine, a Personnalized Immunotherapy in Patients With Metastatic or Locally Advanced Colon Cancer or Pancreatic Cancer

Clinical trial NCT07587827 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07587827
Sponsor: Centre Georges Francois Leclerc
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer (CRC)Locally Advanced Colorectal Cancer Metastatic Pancreatic Cancer Locally Advanced Pancreatic Cancer

Start date: 2026-11-01
Primary completion: 2027-05-01
Enrollment: 77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.